| Industry
Industry name |
Pharmaceuticals |
| Variance
Full Year Net Profit Variance |
-1532 |
| Equity
Latest Equity |
50.1 |
| Face Value
Latest Face Value |
10 |
| Reserves
Total Reserve |
-0.48 |
| Dividend
Full Year Dividend % |
0 |
| Sales Turnover
Full Year Net Sales |
25.14 |
| Net Profit
Full Year Net Profit |
-13.05 |
| Full Year CPS
Full Year Cash Per Share |
-1.4 |
| Earning Per Share
Full Year Earning Per Share |
-2.6 |
| Quarter CPS
Latest quarter Cash Per Share |
0 |
| Latest Quarter Date
Latest Quarter Yrc |
Jun 1, 2026 |
| Latest Quarter Sales
Latest Quarter Net Sales |
1.23 |
| Previous EPS
Previous earnings per share |
0 |
| Book Value
Book value |
9.9 |
| Networth
Full Year Return on Networth |
0 |
| Price/Book Value
Price to Book value |
0.707071 |
| Yearly PE ratio
Full Year Price to Earning per share |
-2.7 |
| Yearly PC ratio
Full Year Price to Cash Per Share |
-5 |
| Bse value
BSE Value in lakhs |
0.79 |
| Nse value
NSE Value in lakhs |
1.68 |
| High
52 week high |
14 |
| Low
52 week low |
6 |
| Price
NSE Current market price |
7 |
| CPM
Current market price |
7 |
| Market cap
BSE / NSE Market Cap |
33.82 |
| Net profit
Latest Quarter Net Profit |
-3.12 |
| Net profit variance
Latest Quarter Net Profit variance |
-472 |
| Result year
Trailing latest month |
Jun 1, 2026 |
| TTM Sales
Trailing Twelve 12 month Net Sales |
119.71 |
| TTM OP
Trailing Twelve 12 month Operating Profit |
-8.17 |
| TTM OPM
Trailing Twelve 12 month Operating Profit Margin |
-6.83 |
| TTM GP
Trailing Twelve 12 month Gross Profit |
-9.53 |
| TTM GPM
Trailing Twelve 12 month Gross Profit Margin |
-149.94 |
| TTM NP
Trailing Twelve 12 month Net Profit |
-13.95 |
| TTM NPV
Trailing Twelve 12 month Net Profit Variane |
-545.14 |
| TTM EPS
Trailing Twelve 12 month EPS |
0 |
| TTM PE
Trailing Twelve 12 month PE |
0 |
| TTM CPS
Trailing Twelve 12 month CPS |
0 |
| Month CPS
Month Cash Per Share |
0 |
| TTM Depreciation
Trailing Twelve 12 month Depreciation |
10.95 |
| Equity
Latest Equity |
50.1 |
| LTP
Latest Price (BSE/NSE) |
7 |
| Gross block
Latest Gross Block |
128.04 |
| Loans
Total loans |
2.13 |
| Advances
Latest Advances for Banks |
0 |
| Net profit asset
Latest Assets |
0 |
| Year OPM
Full Year Operating Profit Margin |
-29.3 |
| Year GPM
Full Year Gross Profit Margin |
-30 |
| Quarter OPM
Latest quater Operation Profit Margin |
-113.4 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| + Sales | 39 | 33 | 39 | 20 | 3 | 2 | 0 | 1 |
| YOY Sales Growth % | 62% | 24% | 72% | -35% | -92% | -93% | -100% | -94% |
| Gross Sales | 39 | 33 | 39 | 20 | 3 | 2 | 0 | 1 |
| + Expenses | 39 | 33 | 60 | 41 | 7 | 3 | 2 | 3 |
| Material Cost % | 74% | 82% | 90% | 58% | 102% | -58% | -746% | 28% |
| Raw Material Cost | 30 | 26 | 32 | 14 | 4 | 0 | 1 | 1 |
| Change in Inventory | -1 | 1 | 3 | -2 | -1 | -2 | 0 | -1 |
| Manufacturing Cost % | 15% | 21% | 76% | 121% | 24% | 24% | -1569% | 87% |
| Employee Cost % | 4% | 4% | 4% | 6% | 25% | 7% | -38% | 15% |
| Other Cost % | 5% | -8% | -17% | 20% | 79% | 161% | 469% | 122% |
| Raw Materials % | 77% | 78% | 81% | 68% | 142% | 22% | -515% | 89% |
| Stock Adjustments % | 3% | -4% | -9% | 10% | 39% | 80% | 231% | 61% |
| Other Manufacturing Expenses % | 15% | 21% | 76% | 121% | 24% | 24% | -1569% | 87% |
| Operating Profit | 1 | 0 | -21 | -21 | -4 | -1 | -3 | -2 |
| OPM % | 2% | 1% | -52% | -105% | -131% | -34% | 1985% | -152% |
| + Other Income | 2 | 9 | 2 | 0 | 0 | 0 | 0 | 0 |
| Miscellaneous Income | 2 | 9 | 2 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 3 | 3 | 4 | 2 | 2 | 2 | 1 | 2 |
| Profit before tax | -1 | 6 | -22 | -23 | -6 | -2 | -4 | -3 |
| + Tax % | -147% | 7% | 35% | 6% | -10% | -6% | -5% | -3% |
| Deferred Tax | 2 | 0 | -8 | -1 | 1 | 0 | 0 | 0 |
| + Net Profit | -3 | 5 | -14 | -21 | -6 | -3 | -4 | -4 |
| Extraordinary Income / Expense | 0 | 8 | -24 | -21 | 0 | 0 | 0 | 0 |
| Exceptional Item | 0 | 8 | -24 | -21 | 0 | 0 | 0 | 0 |
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Sales | 0 | 218 | 246 | 170 | 167 | 202 | 137 | 130 | 104 | 142 |
| Sales Growth % | 13% | -31% | -1% | 21% | -32% | -6% | -19% | 37% | ||
| Gross Sales | 241 | 170 | 167 | 202 | 137 | 130 | 104 | 142 | ||
| Excise Duty | 0 | 19 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Expenses | 0 | 201 | 199 | 156 | 137 | 156 | 130 | 159 | 111 | 152 |
| Material Cost % | 60% | 70% | 75% | 57% | 56% | 67% | 82% | 72% | 75% | |
| Raw Material Cost | 0 | 142 | 172 | 126 | 87 | 102 | 94 | 110 | 79 | 108 |
| Change in Inventory | 0 | -11 | -1 | 2 | 8 | 10 | -3 | -4 | -4 | -2 |
| Manufacturing Cost % | 4% | 6% | 8% | 9% | 9% | 9% | 11% | 15% | 0% | |
| Employee Cost % | 4% | 4% | 7% | 8% | 7% | 5% | 5% | 5% | 4% | |
| Other Cost % | 23% | 1% | 2% | 8% | 6% | 14% | 25% | 14% | 28% | |
| Raw Materials % | 65% | 70% | 74% | 52% | 50% | 69% | 85% | 76% | 76% | |
| Purchase of Finished Goods % | 0% | 25% | 0% | 1% | 5% | 0% | 0% | 0% | ||
| Stock Adjustments % | 5% | 0% | -1% | -5% | -5% | 2% | 3% | 4% | 1% | |
| Power & Fuel % | 3% | 3% | 4% | 5% | 4% | 5% | 6% | 7% | 0% | |
| Other Manufacturing Expenses % | 2% | 3% | 4% | 5% | 5% | 4% | 5% | 8% | 0% | |
| Selling & Administration % | 1% | 2% | 3% | 4% | 5% | 7% | 5% | 5% | 0% | |
| Miscellaneous Expenses % | 12% | 1% | 1% | 4% | 0% | 7% | 17% | 9% | 28% | |
| Operating Profit | 0 | 17 | 47 | 14 | 30 | 47 | 8 | -29 | -7 | -9 |
| OPM % | 8% | 19% | 8% | 18% | 23% | 6% | -22% | -6% | -7% | |
| + Other Income | 0 | 2 | 3 | 0 | 0 | 0 | 0 | 2 | 0 | 5 |
| Miscellaneous Income | 3 | 3 | 0 | 0 | 4 | 2 | 0 | 13 | ||
| Exceptional Income | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 8 | ||
| Interest | 0 | 12 | 11 | 8 | 8 | 2 | 0 | 4 | 2 | 3 |
| Depreciation | 0 | 8 | 18 | 19 | 17 | 16 | 15 | 13 | 11 | 12 |
| Profit before tax | 21 | -16 | 5 | 29 | -6 | -42 | -19 | -19 | ||
| + Tax % | 14% | 25% | 23% | 23% | 13% | 9% | -14% | 24% | ||
| Current Tax | 0 | 0 | 3 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Deferred Tax | 0 | 0 | 0 | -5 | 0 | 6 | -1 | -4 | 3 | -5 |
| + Net Profit | 18 | -12 | 4 | 23 | -5 | -39 | -22 | -15 | ||
| Profit Growth % | -168% | -130% | 528% | -124% | 620% | -44% | -32% | |||
| Extraordinary Income / Expense | 0 | 0 | 0 | 0 | -8 | -22 | -9 | -16 | ||
| Exceptional Item | 0 | 0 | 0 | 0 | -8 | -22 | -9 | -16 | ||
| EPS in Rs |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0 | 0 | 23 | 23 | 41 | 41 | 50 | 50 | 50 | 50 |
| Reserves | 0 | 75 | 94 | 82 | 101 | 118 | 108 | 68 | 47 | 34 |
| + Borrowings | 0 | 116 | 107 | 85 | 48 | 19 | 20 | 22 | 22 | 2 |
| Secured Borrowings | 0 | 55 | 46 | 39 | 34 | 0 | 0 | 22 | 22 | 0 |
| Unsecured Borrowings | 0 | 61 | 61 | 46 | 14 | 19 | 20 | 0 | 0 | 2 |
| + Other Liabilities | 0 | 37 | 63 | 69 | 42 | 29 | 31 | 24 | 32 | 16 |
| Current Liabilities | 0 | 45 | 79 | 82 | 54 | 29 | 31 | 24 | 32 | 15 |
| Provisions | 0 | 4 | 4 | 2 | 5 | 6 | 6 | 10 | 11 | 2 |
| Equity Share Warrants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Other liability items | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Total Liabilities | 0 | 228 | 287 | 258 | 232 | 208 | 209 | 164 | 151 | 102 |
| + Fixed Assets | 0 | 119 | 170 | 162 | 152 | 143 | 137 | 119 | 110 | 68 |
| Gross Block | 0 | 132 | 201 | 212 | 220 | 226 | 234 | 229 | 230 | 128 |
| Accumulated Depreciation | 0 | 13 | 31 | 50 | 67 | 83 | 96 | 110 | 120 | 60 |
| CWIP | 0 | 30 | 7 | 7 | 0 | 0 | 5 | 5 | 3 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| + Other Assets | 0 | 80 | 110 | 90 | 80 | 65 | 67 | 40 | 39 | 33 |
| Inventories | 0 | 33 | 42 | 32 | 26 | 17 | 12 | 14 | 19 | 25 |
| Trade receivables | 0 | 35 | 42 | 29 | 21 | 15 | 19 | 2 | 4 | 1 |
| Cash Equivalents | 0 | 1 | 3 | 3 | 6 | 4 | 17 | 2 | 2 | 1 |
| Loans n Advances | 0 | 18 | 39 | 40 | 39 | 28 | 19 | 21 | 14 | 6 |
| Other asset items | 0 | -7 | -16 | -13 | -12 | 1 | 0 | 0 | 0 | 1 |
| Total Assets | 0 | 228 | 287 | 258 | 232 | 208 | 209 | 164 | 151 | 102 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| + Cash from Operating Activity | 0 | -3 | 40 | 41 | 14 | 41 | 9 | -17 | 2 | -3 |
| Profit Before Tax & Extraordinary Items | 0 | 2 | 15 | -16 | 5 | 29 | 2 | -22 | -19 | -19 |
| Depreciation | 0 | 8 | 18 | 19 | 17 | 16 | 15 | 13 | 11 | 12 |
| Interest (Net) | 0 | 10 | 8 | 8 | 8 | 2 | 0 | 2 | 2 | 3 |
| Profit / Loss on Sale of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Provisions & Write-offs (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -6 | 7 |
| Receivables | 0 | -14 | -7 | 13 | 8 | 6 | -4 | 16 | 5 | 2 |
| Inventories | 0 | -14 | -9 | 11 | 5 | 9 | 6 | -2 | -5 | -5 |
| Trade Payables | 0 | -7 | 23 | 12 | -26 | -21 | 3 | -7 | 5 | -4 |
| Loans & Advances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Borrowing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Direct Taxes Paid | 0 | 0 | -2 | -4 | 0 | 0 | -3 | 0 | 0 | 0 |
| + Cash from Investing Activity | 0 | 0 | -44 | -7 | -2 | -4 | -3 | 11 | 0 | 8 |
| Purchase of Fixed Assets | 0 | -2 | -47 | -11 | -1 | -7 | 0 | 0 | -2 | 0 |
| Sale of Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 1 | 8 |
| Interest Received | 0 | 2 | 3 | 4 | 0 | 0 | 0 | 2 | 0 | 0 |
| Others | 0 | 0 | -1 | 0 | -1 | 3 | -6 | 5 | 1 | 0 |
| + Cash from Financing Activity | 0 | 0 | 4 | -33 | -10 | -36 | 0 | -4 | -2 | -6 |
| Proceeds from Issue of Shares | 0 | 0 | 30 | 0 | 33 | 0 | 0 | 0 | 0 | 0 |
| Proceeds from Other Long-Term Borrowings | 0 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Proceeds from Short-Term Borrowings | 0 | 6 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Repayment of Long-Term Borrowings | 0 | 0 | -20 | -15 | -32 | -14 | 0 | 0 | 0 | 0 |
| Repayment of Short-Term Borrowings | 0 | 0 | 0 | -7 | -3 | -20 | 0 | 0 | 0 | -5 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Net Cash Flow | 0 | -3 | 0 | 0 | 2 | 1 | 6 | -10 | 0 | 0 |